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Abstract 
 
Background: WEE1 is a G2/M checkpoint regulator protein. Various studies have indicated 
that WEE1 could be a good target for cancer therapy. The main aim of this study was to 
asssess the tumor suppressive potential of WEE1 silencing in two different breast cancer cell 
lines, MCF7 which carries the wild-type p53 and MDA-MB468 which contains a mutant 
type. Materials and Methods: After WEE1 knockdown with specific shRNAs downstream 
effects on cell viability and cell cycle progression were determined using MTT and flow 
cytometry analyses, respectively. Real-time PCR and Western blotting were conducted to 
assess the effect of WEE1 inhibition on the expression of apoptotic (p53) and anti-apoptotic 
(Bcl2) factors and also a growth marker (VEGF). Results: The results showed that WEE1 
inhibition could cause a significant decrease in the viability of both MCF7 and MDA-MB-
468 breast cancer cell lines by more than 50%. Interestingly, DNA content assays showed a 
significant increase in apoptotic cells following WEE1 silencing. WEE1 inhibition also 
induced upregulation of the apoptotic marker, p53, in breast cancer cells. A significant 
decrease in the expression of VEGF and Bcl-2 was observed following WEE1 inhibition in 
both cell lines. Conclusions: In concordance with previous studies, our data showed that 
WEE1 inhibition could induce G2 arrest abrogation and consequent cell death in breast 
cancer cells. Moreover, in this study, the observed interactions between the pro- and anti-
apoptotic proteins and decrease in the angiogenesis marker expression confirm the 
susceptibility to apoptosis and validate the tumor suppressive effect of WEE1 inhibition in 
breast cancer cells. Interestingly, the levels of the sensitivity to WEE1 silencing in breast 
cancer cells, MCF7 and MDA-MB468, seem to be in concordance with the level of p53 
expression. 
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